Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
Department of Pulmonary & Critical Care, Icahn School of Medicine at Mount Sinai, New York, USA.
J Med Virol. 2021 Jul;93(7):4537-4543. doi: 10.1002/jmv.26738. Epub 2021 Mar 25.
Data are conflicting regarding the impact of tobacco smoking in people with pneumonia due to SARS-CoV-2 infection (COVID-19). We performed a retrospective multicentre cohort study of 9991 consecutive patients hospitalized in a major New York academic center between March 7th and June 5th, 2020 with laboratory-confirmed COVID-19. The clinical outcomes assessed included risk of hospitalization, in-hospital mortality, risk of intensive care unit (ICU) admission, and need for mechanical ventilation among smokers (current and former). Multivariable logistic regression and propensity score models were built to adjust for potential confounders. Among 9991 consecutive patients diagnosed with COVID-19, 2212 (22.1%) patients were self-reported smokers (406 current and 1806 former). Current smoking was not associated with an increased risk of hospitalization (propensity score [PS]-adjusted OR 0.91; p = .46), in-hospital mortality (PS-OR 0.77; p = .12), ICU admission (PS-OR 1.18; p = .37), or intubation (PS-OR 1.04; p = .85). Similarly, former smoking was not associated with an increased risk of hospitalization (PS-OR 0.88; p = .11), in-hospital mortality (PS-OR 1.03; p = .78), ICU admission (PS-OR 1.03; p = .95), or intubation (PS-OR 0.93; p = .57). Furthermore, smoking (current or former) was not associated with an increased risk of hospitalization (PS-OR 0.85; p = .05), in-hospital mortality (PS-OR 0.94; p = .49), ICU admission (PS-OR 0.86; p = .17), or intubation (PS-OR 0.79; p = .06). Smoking is a well-known risk factor associated with greater susceptibility and subsequent increased severity of respiratory infections. In the current COVID-19 pandemic, smokers may have increased risk and severe pneumonia. In the current COVID-19 pandemic, smokers are believed to have an increased risk of mortality as well as severe pneumonia. However, in our analysis of real-world clinical data, smoking was not associated with increased in-patient mortality in COVID-19 pneumonia, in accordance with prior reports.
数据对于吸烟对 SARS-CoV-2 感染(COVID-19)所致肺炎患者的影响存在争议。我们对 2020 年 3 月 7 日至 6 月 5 日期间在纽约一家主要学术中心住院的 9991 例经实验室确诊为 COVID-19 的连续患者进行了回顾性多中心队列研究。评估的临床结局包括住院风险、住院死亡率、入住重症监护病房(ICU)的风险以及吸烟者(目前和曾经)需要机械通气。使用多变量逻辑回归和倾向评分模型来调整潜在的混杂因素。在 9991 例连续确诊 COVID-19 的患者中,2212 例(22.1%)患者自述为吸烟者(406 例为当前吸烟者,1806 例为曾经吸烟者)。目前吸烟与住院风险增加无关(倾向评分[PS]-调整的比值比[OR]0.91;p=0.46)、住院死亡率(PS-OR 0.77;p=0.12)、入住 ICU(PS-OR 1.18;p=0.37)或插管(PS-OR 1.04;p=0.85)。同样,曾经吸烟与住院风险增加无关(PS-OR 0.88;p=0.11)、住院死亡率(PS-OR 1.03;p=0.78)、入住 ICU(PS-OR 1.03;p=0.95)或插管(PS-OR 0.93;p=0.57)。此外,吸烟(目前或曾经)与住院风险增加无关(PS-OR 0.85;p=0.05)、住院死亡率(PS-OR 0.94;p=0.49)、入住 ICU(PS-OR 0.86;p=0.17)或插管(PS-OR 0.79;p=0.06)。吸烟是一种众所周知的危险因素,与更大的易感性和随后呼吸道感染的严重程度增加有关。在当前的 COVID-19 大流行中,吸烟者可能有更高的风险和更严重的肺炎。在当前的 COVID-19 大流行中,吸烟者被认为有更高的死亡率和严重的肺炎风险。然而,根据我们对真实世界临床数据的分析,吸烟与 COVID-19 肺炎住院患者的死亡率增加无关,这与之前的报告一致。